Can a short video and counseling session reduce HIV stigma in pregnancy care?
NCT ID NCT03600142
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This study tests a program called Maisha (Swahili for 'life') that aims to reduce HIV stigma among pregnant women and their male partners entering antenatal care in Tanzania. The program includes a video and counseling session before HIV testing, plus extra support for those who test positive. Researchers will measure whether the program helps women stay engaged in HIV care and reduces stigma among all participants.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Maisha stigma-reduction counseling program
- What this could lead to
- If effective, this program could help more pregnant women with HIV stay in care and reduce stigma in antenatal settings.
- What could go wrong
- This is a pilot study in two clinics in Tanzania, so results may not apply broadly. Stigma is complex and a brief intervention may not be enough to change deep-rooted attitudes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
1,539 people
The number who actually took part.
- Started
-
Apr 2019
- Finished
-
Mar 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18 years of age or older * If female: Pregnant and attending first antenatal care (ANC) appointment for the current pregnancy at one of the two study sites * If male: Accompanying an enrolled woman to her first ANC appointment. Exclusion Criteria: * Impaired mental status * Does not speak Swahili
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV infections are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kilimanjaro Christian Medical Centre
Moshi, Tanzania
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Virologic outcomes of Lamivudine/Dolutegravir in virologically suppressed subjects with expected or confirmed resistance to lamivudine.
- Can a 6-hour online course change how nurses treat HIV patients?
- Can a blood bank unlock the secrets of HIV control?
- Can a global patient registry improve anal cancer care for people with HIV?
- Gut bacteria pill may shield HIV patients from heart disease
- Peer power: could support groups boost HIV prevention in transgender men?